Advertisement

Topics

European Organisation for Research and Treatment of Cancer (EORTC) Company Profile

02:33 EDT 23rd June 2018 | BioPortfolio

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients’ quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individualEuropean laboratories and hospitals, and can best be accomplished through the multidisciplinary, multinational efforts of basic research scientists and clinicians from the European continent. During the last few years, numerous innovative agents have been discovered as a result of tremendous development in the understanding of the molecular basis of cancer. Further clinical progress in cancer
treatment will be accomplished mainly through the conduct of translational research projects, efficient drug development and the execution of large, prospective, randomized, multicenter cancer clinical trials. EORTC promotes multidisciplinary cancer research in Europe and is linked to other leading biomedical research organizations around the world. EORTC has the aim to facilitate the passage of experimental discoveries into state-of-the-art treatment by keeping to a minimum the time lapse between the discovery of new anti-cancer agents and the implementation of their therapeutic benefit for patients with cancer. The ultimate goal of the EORTC is to improve the standard of cancer treatment in Europe, through the development of innovative drugs, and to establish more effective therapeutic strategies, using drugs already commercially available, or surgery and radiotherapy.

Location

Avenue E. Mounier, 83/11
Brussels
1200
Belgium


News Articles [6868 Associated News Articles listed on BioPortfolio]

Keytruda prolongs recurrence-free survival in melanoma, study shows

MSD and the European Organisation for Research and Treatment of Cancer (EORTC) have released new data showing that the anti-PD-1 therapy Keytruda significantly prolonged recurrence-free survival (RFS)...

Tacklng inefficiencies in cancer care

On 30 January 2018, the All.Can initiative, the Association of European Cancer Leagues (ECL), the European CanCer Organisation (ECCO), and the European Cancer Patient Coalition (ECPC) led a seminar wi...

Keytruda Significantly Improved Recurrence-Free Survival in Patients with Stage 3 Melanoma

CancerConnect News:  The European Organisation for Research and Treatment of Cancer (EORTC), today announced that the phase 3 EORTC1325/KEYNOTE-054 trial […] The post Keytruda Significantly Imp...

Soft chemotherapy is very effective in older patients when added to targeted treatment in an aggressive breast cancer subtype

(European Organisation for Research and Treatment of Cancer) A trial published todayin The Lancet Oncology, shows that, in older patients with HER2 positive metastatic breast cancer (an aggressive br...

Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clinical Trial Enrollment

Foundation Medicine, Inc. (NASDAQ:FMI) and the European Organisation for Research and Treatment of Cancer (EORTC) announced today a collaboration in which Foundation Medici...

'Soft' chemotherapy effective in older patients when added to targeted treatment in aggressive breast cancer subtype

Avoidance of side-effects of chemotherapy is particularly important in the elderly, but finding the balance between reduced toxicity and maximum effectiveness is not always easy. A trial carried out ...

Women with DCIS at lowest risk of recurrence if they are post-menopausal or ER+

(ECCO-the European CanCer Organisation) Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positiv...

Fewer breast cancer patients need radical surgery if they are pre-treated with targeted drugs

(ECCO-the European CanCer Organisation) Extensive surgery involving mastectomy and removal of several lymph nodes can be safely avoided for more women with some types of breast cancer, if they receive...

PubMed Articles [14694 Associated PubMed Articles listed on BioPortfolio]

International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.

The aim was to carry out phase 4 international field-testing of the European Organisation for Research and Treatment of Cancer (EORTC) breast reconstruction (BRECON) module. The primary objective was ...

Reference data of the EORTC QLQ-C30 questionnaire: five consecutive annual assessments of approximately 2000 representative Dutch men and women.

Cancer and its treatment have an influence on health-related quality of life (HRQOL). Normative data could help to interpret HRQOL among cancer patients. Our aim was to generate longitudinal normative...

Oral health-related quality of life in cancer patients.

To date, only a few studies have investigated oral health-related quality of life (OH-QoL) in cancer patients. The European Organisation for Research and Treatment of Cancer (EORTC) has therefore deve...

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.

The European Organisation for Research and Treatment of Cancer (EORTC) 22033-26033 clinical trial (NCT00182819) investigated whether initial temozolomide (TMZ) chemotherapy confers survival advantage ...

Review of HaNDLE-on-QoL: a database of published papers that use questionnaires to report quality of life in patients with cancer of the head and neck.

HaNDLE-on-QoL (Head And Neck Database Listing Evidence on QoL) is a searchable database that comprises abstracts of papers that have used questionnaires to report on quality of life (QoL) in patients ...

Clinical Trials [12988 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Validation Study of the Korean Version of the EORTC QLQ-HDC29

The aim of this study is to evaluate the reliability and validity of the Korean version of the European Organization for Research and Treatment of Cancer High-dose Chemotherapy module (EOR...

Clinical Decision-making, Prognosis, Quality of Life and Satisfaction With Care in Patients With Relapsed/Refractory Multiple Myeloma

The primary objective is overall survival (OS) as predicted by baseline self-reported EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnair...

Calcium Electroporation for Head and Neck Cancer

In a phase I protocol to primarily investigate the safety of using calcium combined with electroporation on recurrent head and neck cancers. Secondly, to evaluate tumour response on PET/MR...

Quality of Life in Patients With Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related mortality worldwide. Despite the recent advances in the treatment of HCC, the ...

Companies [4447 Associated Companies listed on BioPortfolio]

European Organisation for Research and Treatment of Cancer (EORTC)

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate laboratory and clinical research in Europe to improve the manageme...

European Plant Science Organisation

EPSO, the European Plant Science Organisation, is an independent body that represents more than 50 leading Research Institutions from 23 European countries. EPSO wants to improve impact and visibility...

Cancer Treatment Research and Educational Institute

The non-profit Cancer Treatment Research and Educational Institute was founded in 1993 by Karel A. Dicke, M.D., Ph.D. for the purpose of research and education into new developmen...

EURORDIS European Organisation for Rare Diseases

Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc. (OTCBB: BZYR) is a biopharmaceutical company committed to developing treatment for cancer based on genomic and epigenomic principles. Research a...

More Information about "European Organisation for Research and Treatment of Cancer (EORTC)" on BioPortfolio

We have published hundreds of European Organisation for Research and Treatment of Cancer (EORTC) news stories on BioPortfolio along with dozens of European Organisation for Research and Treatment of Cancer (EORTC) Clinical Trials and PubMed Articles about European Organisation for Research and Treatment of Cancer (EORTC) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Organisation for Research and Treatment of Cancer (EORTC) Companies in our database. You can also find out about relevant European Organisation for Research and Treatment of Cancer (EORTC) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record